Can a name change transform PCOS outcomes for women?

The US supreme court has preserved nationwide access to mail-order abortion pills – for now. As Carter Sherman explains, the fight to protect this medication is far from over, as a nationwide, near-total abortion ban could be on the horizon. Carter speaks with Dr Angel Foster, co-founder of the Massachusetts Medication Abortion Access Project, who reveals how the legal battle over abortion pills has affected patients across the US – and what could happen next. Help support our independent journalism at theguardian.com/sciencepod

After more than a decade of global consultation, polycystic ovary syndrome – which affects as many as one in eight women – has been renamed. The condition is caused by high levels of androgens, which can lead to symptoms such as excess hair, weight gain and irregular periods. To understand why campaigners wanted it renamed, and what its new name – polyendocrine metabolic ovarian syndrome (PMOS) – could mean for patients, Madeleine Finlay hears from the Guardian’s science correspondent, Nicola Davis, and Rachel, a campaigner from the charity Verity. Help support our independent journalism at theguardian.com/sciencepod

An outbreak of Ebola has emerged in the Democratic Republic of Congo and Uganda, leading to nearly 400 confirmed cases and more than 100 deaths. To find out how the outbreak might have begun, what authorities can do to contain it and why this outbreak is causing particular concern, Ian Sample hears from Daniela Manno, a clinical epidemiologist at the London School of Hygiene and Tropical Medicine. Help support our independent journalism at theguardian.com/sciencepod

The US supreme court dealt a devastating blow to the 1965 Voting Rights Act when it ruled in Louisiana v Callais in April that states cannot consider race in redistricting. Southern states from Tennessee to Alabama have rushed to erase majority-Black districts, sparking chaos for the midterm elections. Kai Wright talks to Stacey Abrams, a voting rights activist and former Georgia house minority leader, about the fallout from the decision, and why, despite it all, she still believes the way forward lies in engaging more voters to participate in democracy. ‘They have fractured communities and said we’re going to scatter these seeds. Our job is to grow,’ she says. Help support our independent journalism at theguardian.com/sciencepod

Madeleine Finlay sits down with co-host and science editor Ian Sample to discuss three eyecatching stories from the week, including an update on hantavirus. Also on the agenda is the Pentagon’s release of a tranche of never before seen documents relating to UFOs, and a study looking at the link between taking part in cultural activities and slower biological ageing. Help support our independent journalism at theguardian.com/sciencepod

Last month President Trump signed an executive order designed to fast track both research and access to psychedelic drugs as treatments for mental health illnesses. The most prominent in the order was ibogaine, a drug derived from the root bark of a West African shrub, that has shown some promise in relieving the long term effects of traumatic brain injury. Madeleine Finlay talks to journalist Mattha Busby about podcaster Joe Rogan’s role in the story, what else is behind the President’s interest in psychedelic research, and what the order will change in practice for scientists and researchers. Help support our independent journalism at theguardian.com/sciencepod

To celebrate Sir David Attenborough’s centenary, Madeleine Finlay catches up with natural history writer Patrick Barkham, who has met the celebrated presenter. They explore how the natural world has changed in the century that Attenborough has been on Earth, and how his programming has reflected his growing commitment to highlighting the devastating impacts of the climate crisis on nature and biodiversity. Help support our independent journalism at theguardian.com/sciencepod

Three people have died after an outbreak of hantavirus onboard a cruise ship travelling from Argentina to Cape Verde. The World Health Organization says a total of seven cases – two confirmed by laboratory testing and five suspected – have been identified on the cruise ship so far. It is also investigating whether rare human-to-human transmission of the virus could be behind the cases. Madeleine Finlay talks to Prof Jonathan Ball from Liverpool School of Tropical Medicine to find out where the virus comes from, how it is transmitted to humans, and what health agencies will be doing to try to contain it. Help support our independent journalism at theguardian.com/sciencepod

The transition towards renewable energy received a boost last week when representatives from 57 countries met in Santa Marta, Colombia, for a world-first climate meeting aimed at bringing the fossil fuels era to an end. Madeleine Finlay hears from the Guardian’s global environment editor, Jon Watts, about how the landmark conference came about, who was missing, and whether the optimism can translate into real world action. Help support our independent journalism at theguardian.com/sciencepod

Madeleine Finlay sits down with co-host and Guardian science editor Ian Sample to talk through three eye-catching stories from the week, including the news that the number of years people in the UK are spending in good health has declined compared with a decade ago. Also on the agenda is the science, tech and nutrition behind two runners at this weekend’s London marathon breaking the two-hour threshold, and an answer to why some old houses feel particularly spooky. Help support our independent journalism at theguardian.com/sciencepod